Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196404 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
A Phase 2 study of Urinary Incontinence, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 800
- Enrollment target
- 20
- Study locations
NCT00196404: Completed Phase 2 study of Urinary Incontinence, sponsored by Duramed Research.
NCT00196404 is a Phase 2 study of Urinary Incontinence that has completed, run by Duramed Research. The registered enrollment target is 800 participants, above the 245-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (227% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00196404, a Phase 2 study of Urinary Incontinence, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 800 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a placebo-controlled, double-blind study to evaluate the safety and efficacy of two doses of DR-3001 in women with overactive bladder who have symptoms of predominant or pure urge incontinence, urinary urgency and elevated urinary frequency
Conditions Studied
Interventions
- OTHER Placebo
- DRUG DR-3001a
- DRUG DR-3001b
Study Locations (20)
Alabama
- Duramed Investigational Site - Birmingham
- Duramed Investigational Site - Huntsville
- Duramed Investigational Site - Mobile
Colorado
- Duramed Investigational Site - Aurora
- Duramed Research Site - Colorado Springs
- Duramed Investigational Site - Denver
Indiana
- Duramed Investigational Site - Boise
- Duramed Investigational Site - Evansville
- Duramed Investigational Site - Fort Wayne
Arizona
- Duramed Research Site - Phoenix
- Duramed Research Site - Tucson
California
- Duramed Investigational Site - San Diego
- Duremed Research Site - San Diego
Florida
- Duramed Investigational Site - Aventura
- Duramed Research Site - Gainesville
Georgia
- Duramed Investigational Site - Decatur
- Duramed Research Site - Sandy Springs
Arkansas
- Duramed Investigational Site - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
What the finished NCT00196404 record still lists
NCT00196404 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 245-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (227% higher).
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00196404 names 20 study sites across 10 states, led by Alabama, Colorado, Indiana.
Frequently Asked Questions
What is clinical trial NCT00196404 about?
NCT00196404 is a clinical study titled "Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder". This is a placebo-controlled, double-blind study to evaluate the safety and efficacy of two doses of DR-3001 in women with overactive bladder who have symptoms of predominant or pure urge incontinence, urinary urgency and elevated urinary frequency
What is the current status of trial NCT00196404?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 800 participants. The study started on 2004-10. Estimated completion is 2006-12.
What conditions does trial NCT00196404 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT00196404?
The interventions under investigation include: Placebo (OTHER), DR-3001a (DRUG), DR-3001b (DRUG).
Who is sponsoring clinical trial NCT00196404?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00196404 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00196404's enrollment target sits among peer trials
800 4th of 48 higher than 45 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
RECRUITING · Phase 2
-
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
RECRUITING · Phase 2
-
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
RECRUITING · Phase 2
-
Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence
COMPLETED · Phase 2
-
Urge Incontinence Bladder Overactivity Study
COMPLETED · Phase 2
-
Translating Unique Learning for Incontinence Prevention
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia